Description: Bausch + Lomb Corporation is a Canada-based eye health company. The Company offers lines of contact lenses, intraocular lenses (IOL), medical devices, surgical systems, vitamin and mineral supplements, lens care products, prescription eye-medications and over the counter (OTC) eye health consumer products. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. Vision Care/Consumer Health Care business includes both contact lens and consumer eye care businesses, and includes products, such as Biotrue ONEday daily disposables. Ophthalmic Pharmaceuticals business includes a range of pharmaceutical products for post-operative treatments and treatments for eye conditions, such as glaucoma, eye inflammation, ocular hypertension, and retinal disease. Surgical business includes medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions.
Home Page: www.bausch.com
BLCO Technical Analysis
520 Applewood Crescent
Vaughan,
ON
L4K 4B4
Canada
Phone:
905 695 7700
Officers
| Name | Title |
|---|---|
| Mr. Joseph C. Papa | CEO & Director |
| Mr. Osama A. Eldessouky | Exec. VP & CFO |
| Ms. Christina M. Ackermann | Exec. VP, Gen. Counsel & Pres of Ophthalmic Pharmaceuticals |
| Mr. Joseph F. Gordon | Pres of Global Consumer, Surgical & Vision Care |
| Ms. Kelly Webber | Exec. VP & Chief HR Officer |
| Dr. Yehia Hashad M.D. | Exec. VP of R&D and Chief Medical officer |
| Mr. Louis W. Yu | Exec. VP & Chief Quality Officer |
| Mr. Dennis Asharin | Exec. VP and Chief Global Manufacturing & Supply Chain Officer |
Exchange: TO
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 23.2019 |
|---|---|
| Trailing PE: | 89.7083 |
| Price-to-Book MRQ: | 0.8028 |
| Price-to-Sales TTM: | 1.9258 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 12800 |